A Comparison of Olopatadine and Fluticasone in Patients With Allergic Conjunctivitis
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
To compare the clinical efficacy of olopatadine and fluticasone in a 3-week single center,
double-masked, randomized, placebo controlled parallel treatment conjunctival allergen
challenge (CAC) study in patients with allergic conjunctivitis